New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.

Autoimmun Rev 2014 Feb 12;13(2):114-6. Epub 2013 Oct 12.

Department of Medicine, Department of Neurology and Division of Allergy Immunology, Nassau University Medical Center, East Meadow, NY, USA. Electronic address:

Inflammatory bowel disease (IBD) and multiple sclerosis (MS) are autoimmune diseases with a close relationship to their disease pattern and immunologic cascade with considerable morbidity and mortality. This article provides insight of why tumor necrosis factor blockers couldn't work in multiple sclerosis and why interferon-beta doesn't work in inflammatory bowel disease. In this article, we provide a detailed review of the linkage and potential interchangeable medication between IBD and MS in addition to Natalizumab, Trichuris suis egg therapy and vitamin D. Different treatment strategies may have potential in treating both diseases in the future.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2013.09.011DOI Listing
February 2014
8 Reads

Publication Analysis

Top Keywords

inflammatory bowel
12
multiple sclerosis
12
bowel disease
12
interferon-beta work
4
sclerosis interferon-beta
4
work multiple
4
work inflammatory
4
disease article
4
detailed review
4
provide detailed
4
article provide
4
couldn't work
4
blockers couldn't
4
mortality article
4
morbidity mortality
4
considerable morbidity
4
article insight
4
insight tumor
4
factor blockers
4
necrosis factor
4

Similar Publications